Exact Mass: 196.0589

Exact Mass Matches: 196.0589

Found 79 metabolites which its exact mass value is equals to given mass value 196.0589, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

1,7-dimethylurate

2,8-dihydroxy-1,7-dimethyl-6,7-dihydro-1H-purin-6-one

C7H8N4O3 (196.0596)


1,7 dimethyluric acid is the major urinary caffeine metabolites that is produced in the human body. 1,7 dimethyluric acid is formed during metabolism of caffeine and the process is catalyzed primarily by CYP2A6. (PMID: 18715882) [HMDB] 1,7-Dimethyluric acid is the major urinary caffeine metabolite that is produced in the human body. 1,7-Dimethyluric acid is formed during caffeine metabolism and the process is catalyzed primarily by CYP2A6 (PMID: 18715882).

   

3,7-Dimethyluric acid

3,7-dimethyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione

C7H8N4O3 (196.0596)


3,7-Dimethyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 3,7-Dimethyluric is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID: 11712316, 15833286, 3506820, 15013152) [HMDB] 3,7-Dimethyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 3,7-Dimethyluric is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis (PMID:11712316, 15833286, 3506820, 15013152).

   

Gluconic acid

(2R,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanoic acid

C6H12O7 (196.0583)


Gluconic acid, also known as D-gluconic acid, D-gluconate or (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid (also named dextronic acid), is the C1-oxidized form of D-glucose where the aldehyde group has become oxidized to the corresponding carboxylic acid. Gluconic acid belongs to the class of organic compounds known as sugar acids and derivatives. Sugar acids and derivatives are compounds containing a saccharide unit which bears a carboxylic acid group. In aqueous solution, gluconic acid exists in equilibrium with the cyclic ester glucono delta-lactone. Gluconic acid occurs naturally in fruit, honey, kombucha tea and wine. The salts of gluconic acid are known as "gluconates". Gluconic acid, gluconate salts, and gluconate esters occur widely in nature because such species arise from the oxidation of glucose. Gluconic acid exists in all living species, ranging from bacteria to plants to humans. The metabolism of gluconate is well characterized in prokaryotes where it is known to be degraded following phosphorylation by gluconokinase. Glucokinase activity has also been detected in mammals, including humans (PMID: 24896608). Gluconic acid is produced in the gluconate shunt pathway. In the gluconate shunt, glucose is oxidized by glucose dehydrogenase (also called glucose oxidase) to furnish gluconate, the form in which D-gluconic acid is present at physiological pH. Subsequently, gluconate is phosphorylated by the action of gluconate kinase to produce 6-phosphogluconate, which is the second intermediate of the pentose phosphate pathway. This gluconate shunt is mainly found in plants, algae, cyanobacteria and some bacteria, which all use the Entner–Doudoroff pathway to degrade glucose or gluconate; this generates 2-keto-3-deoxygluconate-6-phosphate, which is then cleaved to generate pyruvate and glyceraldehyde 3-phosphate. Glucose dehydrogenase and gluconate kinase activities are also present in mammals, fission yeast, and flies. Gluconic acid has many industrial uses. It is used as a drug as part of electrolyte supplementation in total parenteral nutrition. It is also used in cleaning products where it helps cleaning up mineral deposits. Gluconic acid or Gluconic acid is used to maintain the cation-anion balance on electrolyte solutions. In humans, gluconic acid is involved in the metabolic disorder called the transaldolase deficiency. Gluconic acid has been found to be a metabolite in Aspergillus (Hugo Vanden Bossche, D.W.R. Mackenzie and G. Cauwenbergh. Aspergillus and Aspergillosis, 1987). [Spectral] D-Gluconic acid (exact mass = 196.0583) and Guanine (exact mass = 151.04941) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. Dietary supplement, acidity regulator approved in Japan. Component of bottle rinsing formulations Acquisition and generation of the data is financially supported in part by CREST/JST. KEIO_ID G031

   

Hamamelose

(2R,3R,4R)-2,3,4,5-tetrahydroxy-2-(hydroxymethyl)pentanoic acid

C6H12O7 (196.0583)


   

Galactonate

(2R,3S,4S,5R)-2,3,4,5,6-pentahydroxyhexanoic acid

C6H12O7 (196.0583)


Galactonic acid is a sugar acid that is a metabolic breakdown product of galactose. Galactose dehydrogenase is responsible for converting galactose to galactonolactone, which then spontaneously or enzymatically converts to galactonic acid. Once formed, galactonic acid may enter the pentose phosphate pathway. Galactonic acid is increased in red blood cells of galactosemic patients, due to a galactose-1-phosphate uridyltransferase (GALT) deficiency (PMID: 14680973, OMMBID: The Online Metabolic and Molecular Bases of Inherited Disease, Ch.72). When present in sufficiently high levels, galactonic acid can act as an acidogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of galactonic acid are associated with at least two inborn errors of metabolism, including galactosemia and galactosemia type II. Galactonic acid is an organic acid. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart abnormalities, liver abnormalities (jaundice), kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated galactosemia. Many affected children with organic acidemias experience intellectual disability or delayed development. High levels of galactonic acid in infants are specifically associated with hepatomegaly (an enlarged liver), cirrhosis, renal failure, cataracts, vomiting, seizure, hypoglycemia, lethargy, brain damage, and ovarian failure. Galactonate is increased in red blood cells of galactosemic patients, due to a galactose-1-phosphate uridyltransferase (GALT) deficiency ((PMID 14680973, OMMBID: The Metabolic and Molecular Bases of Inherited Disease, Ch.72) [HMDB]

   

Gulonate

(2R,3R,4S,5R)-2,3,4,5,6-pentahydroxyhexanoic acid

C6H12O7 (196.0583)


Gulonic acid, also known as gulonate, belongs to the class of organic compounds known as medium-chain hydroxy acids and derivatives. These are hydroxy acids with a 6 to 12 carbon atoms long side chain.It is a gulonic acid having D-configuration. Reduction product of glucuronic acid; oxidation product of l-gulose [HMDB]

   

D-Mannonic acid

(2S,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid

C6H12O7 (196.0583)


   

L-Gluconic acid

2,3,4,5,6-Pentahydroxyhexanoic acid

C6H12O7 (196.0583)


   

Altronic acid

D-altronic acid

C6H12O7 (196.0583)


The D-enantiomer of altronic acid.

   

L-idonic acid

L-idonic acid

C6H12O7 (196.0583)


The L-enantiomer of idonic acid.

   

1,3-dimethylurate

1,3-dimethyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione

C7H8N4O3 (196.0596)


1,3-Dimethyluric acid is a product of theophylline metabolism in man. 1,3-Dimethyluric acid is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID: 11712316, 15833286, 3506820, 15013152, 4039734) [HMDB] 1,3-Dimethyluric acid is a product of theophylline metabolism in man. 1,3-Dimethyluric acid is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID:11712316, 15833286, 3506820, 15013152, 4039734). 1,3-Dimethyluric acid is a product of theophylline metabolism in man. 1,3-Dimethyluric acid is one of the purine components in urinary calculi.

   

1,9-Dimethyluric acid

1,9-dimethyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione

C7H8N4O3 (196.0596)


1,9-Dimethyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 1,9-Methyluracil is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID: 11712316, 15833286, 3506820, 15013152) [HMDB] 1,9-Dimethyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 1,9-Methyluracil is one of the purine components in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. Caffeine is metabolized via successive pathways mainly catalyzed by CYP1A2, xanthine oxidase or N-acetyltransferase-2 to give 14 different metabolites. CYP1A2 activity shows an inter-individual variability among the population. CYP1A2, an isoform of the CYP1A cytochrome P450 super-family, is involved in the metabolism of many drugs and plays a potentially important role in the induction of chemical carcinogenesis. (PMID:11712316, 15833286, 3506820, 15013152).

   

3,9-Dimethyluric acid

3,9-dimethyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione

C7H8N4O3 (196.0596)


3,9-Dimethyluric acid is involved in purine oxidation pathways. Reevaluation of products derived from 3,9-dimethyluric acid in a chlorination-reductive dechlorinaton sequence has demonstrated unequivocally that they are not purines.(PMID 14601976)

   

7,9-Dimethyluric acid

7,9-dimethyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione

C7H8N4O3 (196.0596)


7,9-Dimethyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 7,9-Dimethyluracil is one of the purine component in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. (PMID: 11712316, 15833286, 3506820) [HMDB] 7,9-Dimethyluric acid is a methyl derivative of uric acid, found occasionally in human urine. 7,9-Dimethyluracil is one of the purine component in urinary calculi. Methylated purines originate from the metabolism of methylxanthines (caffeine, theophylline and theobromine). Methyluric acids are indistinguishable from uric acid by simple methods routinely used in clinical laboratories, requiring the use of high-performance liquid chromatography (HPLC). Purine derivatives in urinary calculi could be considered markers of abnormal purine metabolism. The content of a purine derivative in stone depends on its average urinary excretion in the general population, similarity to the chemical structure of uric acid, and content of the latter in stone. This suggests that purines in stones represent a solid solution with uric acid as solvent. It is also plausible that methylxanthines, ubiquitous components of the diet and drugs, are involved in the pathogenesis of urolithiasis. (PMID: 11712316, 15833286, 3506820).

   

2-Carboxyarabinitol

2,3,4,5-tetrahydroxy-2-(hydroxymethyl)pentanoic acid

C6H12O7 (196.0583)


2-carboxyarabinitol is a member of the class of compounds known as hydroxy fatty acids. Hydroxy fatty acids are fatty acids in which the chain bears a hydroxyl group. 2-carboxyarabinitol is soluble (in water) and a weakly acidic compound (based on its pKa). 2-carboxyarabinitol can be found in a number of food items such as tarragon, dandelion, ginkgo nuts, and spinach, which makes 2-carboxyarabinitol a potential biomarker for the consumption of these food products.

   

gluconic acid

D-gluconic acid

C6H12O7 (196.0583)


   

1,3-Dimethylurate

1,3-Dimethyluric acid

C7H8N4O3 (196.0596)


Acquisition and generation of the data is financially supported in part by CREST/JST. 1,3-Dimethyluric acid is a product of theophylline metabolism in man. 1,3-Dimethyluric acid is one of the purine components in urinary calculi.

   

1,9-Dimethyluric acid

7,9-dihydro-1,9-Dimethyl-1H-purine-2,6,8(3H)-trione

C7H8N4O3 (196.0596)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.252 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.253 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.246 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.247

   

D-GULONIC ACID GAMA-LACTONE

D-GULONIC ACID GAMA-LACTONE

C6H12O7 (196.0583)


   

D-gluconate

D-gluconate

C6H12O7 (196.0583)


   

D-gluconic acid

D-Gluconic acid sodium salt

C6H12O7 (196.0583)


A gluconic acid having D-configuration.

   

Galactonic acid

Galactonic acid

C6H12O7 (196.0583)


   

1,3-Dimethyluric acid

1,3-Dimethyluric acid

C7H8N4O3 (196.0596)


An oxopurine that is 7,9-dihydro-1H-purine-2,6,8(3H)-trionesubstituted by methyl groups at N-1 and N-3. 1,3-Dimethyluric acid is a product of theophylline metabolism in man. 1,3-Dimethyluric acid is one of the purine components in urinary calculi.

   

3,7-Dimethyluric acid

3,7-Dimethyluric acid

C7H8N4O3 (196.0596)


An oxopurine that is 7,9-dihydro-1H-purine-2,6,8(3H)-trione substituted by methyl groups at N-3 and N-7.

   

Gulonic acid

(2R,3R,4S,5R)-2,3,4,5,6-pentahydroxyhexanoic acid

C6H12O7 (196.0583)


   

1,7-Dimethyluric acid

1,7-Dimethyluric acid

C7H8N4O3 (196.0596)


An oxopurine that is 7,9-dihydro-1H-purine-2,6,8(3H)-trione substituted by methyl groups at N-1 and N-7. It is a metabolite of caffeine and is often found in human urine samples.

   

Sodium gluconate

Sodium gluconate

C6H12O7 (196.0583)


   

1,3-Dimethyluric acid; LC-tDDA; CE10

1,3-Dimethyluric acid; LC-tDDA; CE10

C7H8N4O3 (196.0596)


   

1,3-Dimethyluric acid; LC-tDDA; CE20

1,3-Dimethyluric acid; LC-tDDA; CE20

C7H8N4O3 (196.0596)


   

1,3-Dimethyluric acid; LC-tDDA; CE30

1,3-Dimethyluric acid; LC-tDDA; CE30

C7H8N4O3 (196.0596)


   

1,3-Dimethyluric acid; LC-tDDA; CE40

1,3-Dimethyluric acid; LC-tDDA; CE40

C7H8N4O3 (196.0596)


   

Gluconic acid; LC-tDDA; CE10

Gluconic acid; LC-tDDA; CE10

C6H12O7 (196.0583)


   

Gluconic acid; LC-tDDA; CE20

Gluconic acid; LC-tDDA; CE20

C6H12O7 (196.0583)


   

Gluconic acid; LC-tDDA; CE30

Gluconic acid; LC-tDDA; CE30

C6H12O7 (196.0583)


   

Gluconic acid; LC-tDDA; CE40

Gluconic acid; LC-tDDA; CE40

C6H12O7 (196.0583)


   

1,7-Dimethyluric acid; LC-tDDA; CE10

1,7-Dimethyluric acid; LC-tDDA; CE10

C7H8N4O3 (196.0596)


   

1,7-Dimethyluric acid; LC-tDDA; CE20

1,7-Dimethyluric acid; LC-tDDA; CE20

C7H8N4O3 (196.0596)


   

1,7-Dimethyluric acid; LC-tDDA; CE30

1,7-Dimethyluric acid; LC-tDDA; CE30

C7H8N4O3 (196.0596)


   

1,7-Dimethyluric acid; LC-tDDA; CE40

1,7-Dimethyluric acid; LC-tDDA; CE40

C7H8N4O3 (196.0596)


   

1,7-Dimethyluric acid; AIF; CE10; CorrDec

1,7-Dimethyluric acid; AIF; CE10; CorrDec

C7H8N4O3 (196.0596)


   

1,7-Dimethyluric acid; AIF; CE30; CorrDec

1,7-Dimethyluric acid; AIF; CE30; CorrDec

C7H8N4O3 (196.0596)


   

1,7-Dimethyluric acid; AIF; CE0; MS2Dec

1,7-Dimethyluric acid; AIF; CE0; MS2Dec

C7H8N4O3 (196.0596)


   

1,7-Dimethyluric acid; AIF; CE10; MS2Dec

1,7-Dimethyluric acid; AIF; CE10; MS2Dec

C7H8N4O3 (196.0596)


   

1,7-Dimethyluric acid; AIF; CE30; MS2Dec

1,7-Dimethyluric acid; AIF; CE30; MS2Dec

C7H8N4O3 (196.0596)


   

1,3-Dimethyluric acid; AIF: CE0; CorrDec

1,3-Dimethyluric acid; AIF: CE0; CorrDec

C7H8N4O3 (196.0596)


   

1,3-Dimethyluric acid; AIF: CE10; CorrDec

1,3-Dimethyluric acid; AIF: CE10; CorrDec

C7H8N4O3 (196.0596)


   

1,3-Dimethyluric acid; AIF: CE30; CorrDec

1,3-Dimethyluric acid; AIF: CE30; CorrDec

C7H8N4O3 (196.0596)


   

1,3-Dimethyluric acid; AIF: CE0; MS2Dec

1,3-Dimethyluric acid; AIF: CE0; MS2Dec

C7H8N4O3 (196.0596)


   

1,3-Dimethyluric acid; AIF: CE10; MS2Dec

1,3-Dimethyluric acid; AIF: CE10; MS2Dec

C7H8N4O3 (196.0596)


   

1,3-Dimethyluric acid; AIF: CE30; MS2Dec

1,3-Dimethyluric acid; AIF: CE30; MS2Dec

C7H8N4O3 (196.0596)


   

gluconate

D-gluconic acid

C6H12O7 (196.0583)


   

Oxytheophylline

1,3-dimethyl-7,9-dihydropurine-2,6,8-trione

C7H8N4O3 (196.0596)


1,3-Dimethyluric acid is a product of theophylline metabolism in man. 1,3-Dimethyluric acid is one of the purine components in urinary calculi.

   

3-sulfopropyltrimethylsilane

3-sulfopropyltrimethylsilane

C6H16O3SSi (196.0589)


   

7,9-Dimethyluric acid

7,9-dihydro-7,9-Dimethyl-1H-purine-2,6,8(3H)-trione

C7H8N4O3 (196.0596)


   

3,9-dimethyluric acid

3,9-dimethyl-2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione

C7H8N4O3 (196.0596)


   

Trimethoxysilylpropanethiol

Trimethoxysilylpropanethiol

C6H16O3SSi (196.0589)


   

3,7-Dithia-1,9-nonanediol

3,7-Dithia-1,9-nonanediol

C7H16O2S2 (196.0592)


   

2-amino-5-nitrobenzohydrazide

2-amino-5-nitrobenzohydrazide

C7H8N4O3 (196.0596)


   

2-METHYL-5-NITRONICOTINOHYDRAZIDE

2-METHYL-5-NITRONICOTINOHYDRAZIDE

C7H8N4O3 (196.0596)


   

Hexonic acid

Hexonic acid

C6H12O7 (196.0583)


   

7,9-Dihydro-3,9-dimethyl-1H-purine-2,6,8(3H)-trione

7,9-Dihydro-3,9-dimethyl-1H-purine-2,6,8(3H)-trione

C7H8N4O3 (196.0596)


   

2,2,3,3,4-Pentahydroxyhexanoic acid

2,2,3,3,4-Pentahydroxyhexanoic acid

C6H12O7 (196.0583)


   

L-Galactonic acid

L-Galactonic acid

C6H12O7 (196.0583)


   

L-Gluconic acid

L-Gluconic acid

C6H12O7 (196.0583)


   

Idonic acid

Idonic acid

C6H12O7 (196.0583)


   

(2R,3R,4S,5S)-2,3,4,5,6-pentahydroxyhexanoic acid

(2R,3R,4S,5S)-2,3,4,5,6-pentahydroxyhexanoic acid

C6H12O7 (196.0583)


   

2-Carboxyribitol

2-Carboxyribitol

C6H12O7 (196.0583)


   

3-(Trimethylsilyl)propane-1-sulfonic acid

3-(Trimethylsilyl)propane-1-sulfonic acid

C6H16O3SSi (196.0589)


   

3-(Trimethylsilyl)-1-propanesulfonic acid-d6

3-(Trimethylsilyl)-1-propanesulfonic acid-d6

C6H16O3SSi (196.0589)


   

D-galactonic acid

D-galactonic acid

C6H12O7 (196.0583)


A galactonic acid compound having D-configuration.

   

D-Mannonic acid

D-Mannonic acid

C6H12O7 (196.0583)


The D-stereoisomer of mannonic acid.

   

L-Gulonic acid

L-Gulonic acid

C6H12O7 (196.0583)


A gulonic acid formed by oxidising the aldehyde group of L-gulose to a carboxylic acid group.

   

2-Carboxy-D-arabinitol

2-Carboxy-D-arabinitol

C6H12O7 (196.0583)


   

D-Gulonic acid

D-Gulonic acid

C6H12O7 (196.0583)


A gulonic acid having D-configuration.

   

L-Galactonate

L-Galactonic acid

C6H12O7 (196.0583)


A galactonic acid compound having L-configuration.

   

7,9-dihydro-7,9-Dimethyl-1H-purine-2,6,8(3H)-trione

7,9-dihydro-7,9-Dimethyl-1H-purine-2,6,8(3H)-trione

C7H8N4O3 (196.0596)


   

Dimethyluric acid

Dimethyluric acid

C7H8N4O3 (196.0596)


   

Mannonic acid

Mannonic acid

C6H12O7 (196.0583)


   

D-(+)-Gluconic acid δ-lactone

D-(+)-Gluconic acid δ-lactone

C6H12O7 (196.0583)